Pinpointing Global Expertise in Non-Alcoholic Fatty Liver Disease (NAFLD) Digital Science 10.6084/m9.figshare.8004002.v1 https://digitalscience.figshare.com/articles/poster/Pinpointing_Global_Expertise_in_Non-Alcoholic_Fatty_Liver_Disease_NAFLD_/8004002 Disease types associated with NAFLD present a tremendous research and development challenge for life sciences organizations and also a great opportunity for them to create value and innovation.<br><br>The NASH market alone was valued at $1,179 million in 2017, and is expected to reach $21,478 million by 2025, growing at a CAGR of 58.4% from 2021 to 2025 1.<br><br>Digital Science offers the data capabilities to help information services leaders, discovery scientists, CI analysts, knowledge management, partnering and business development professionals uncover insights and expertise in disease-related topics and key indication areas.<br><br>This graphic shows some example insights in non-alcoholic fatty liver disease (NAFLD) and its common disease type NASH (non-alcoholic steatohepatitis) extracted from our Dimensions platform: <a href="https://app.dimensions.ai/discover/publication">https://app.dimensions.ai/discover/publication</a>. 2019-04-17 10:00:35 Non Alcoholic Fatty Liver Disease NAFLD Expertise pharmacology/drug resistance Non-alcoholic steatohepatitis (NASH) Dimensions disease Library and Information Studies Medicine Pharmacology